“We had to choose whether to stop [treatment] and let him go, or push forward and try [to save him] with all the drugs and therapies possible, running the very high risk of damaging other organ ...

Patient was a 16-year-old teen, who underwent treatment in Dec First death reported after Elevidys treatment Liver injury a known risk with gene therapies March 18 (Reuters) - Sarepta Therapeutics ...